ipo subscription
- H
Sai Parenteral IPO: 41% Subscription on Day 2
New Delhi, March 25 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, saw 41 per cent subscription on the second day of the share sale on Wednesday.The IPO received bids for 30,82,788 shares against 75,22,486 shares on offer, according to...- Himanshu
- Thread
- anchor investors contract development and manufacturing organization equity shares global formulations initial public offering injectable products ipo subscription new delhi oral solid dosage formulations pharmaceutical formulation price band qualified institutional buyers retail individual investors sai parenteral's ltd
- Replies: 0
- Forum: Business
- H
Pharmaceutical IPO: Sai Parenteral's Initial Offering
Sai Parenteral’s IPO Receives 4% Subscription on First Day New Delhi, March 24 – The initial public offering (IPO) of Sai Parenteral’s Ltd, a diversified pharmaceutical formulation company, received a 4% subscription on Tuesday, the first day of bidding.Initial Bidding Figures According to...- Himanshu
- Thread
- capital markets contract development and manufacturing organization equity shares global formulations india initial public offering injectable products investment ipo subscription new delhi oral solid dosage formulations pharmaceutical formulation price band public offering sai parenteral
- Replies: 0
- Forum: Business